FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a cell line containing a gene stably integrated into its genome, encoding tetracycline repressor (Tet-R), under control of CAG promotor. A method for the production of infectious viral particles is also disclosed, providing the use of cells of the above-mentioned cell line.
EFFECT: invention is effective for the production of infectious viral particles.
10 cl, 11 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SELF-INACTIVATED HELPER ADENOVIRUSES FOR PREPARING HIGH-CAPACITY RECOMBINANT ADENOVIRUSES | 2009 |
|
RU2520809C2 |
| HERPETIC FEVER VIRUS VACCINES | 2010 |
|
RU2575067C2 |
| EFFICIENT AND BALANCED BIDIRECTIONAL PROMOTOR | 2017 |
|
RU2745500C2 |
| EFFECTIVE AND BALANCED BIDIRECTIONAL PROMOTER | 2017 |
|
RU2758238C2 |
| STABLE CELL LINES FOR RETROVIRUSES PRODUCTION | 2016 |
|
RU2752498C2 |
| F-PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS AND ITS USE | 2007 |
|
RU2464316C2 |
| METHOD OF PRODUCING TARGET VIRUS OR TARGET PROTEINS DIFFERENT FROM ADENOVIRUS, EXPRESSION CELL AND HOST CELL AND PRODUCTION METHODS THEREOF, USE OF EXPRESSION CELL | 2006 |
|
RU2449015C2 |
| IMMORTALISED CELL LINE OF BIRDS | 2008 |
|
RU2475536C2 |
| AVIAN TELOMERASE REVERSE TRANSCRIPTASE | 2007 |
|
RU2415867C2 |
| IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
